| Lonza Group AG | 633.9200 / +0.44% |
| Date/Time | 03/01 / 21:54 |
| Chg. / Chg.(%) | 2.7900 / +0.44% |
| Bid | - |
| Ask | - |
| Open | 632.5000 |
| Previous Close | 631.1300 |
| High | 633.9200 |
| Low | 632.0000 |
| Volume [USD] | 22,782.8320 |
| Volume [Units] | 36 |
| Price fixings | 6 |
| ISIN | CH0013841017 |
| Security | LZAGF |
| Exchange | Nasdaq Other OTC |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 575.60 |  |
229,696 |
| London Inter.. | 576.05 |  |
18,784 |
| Cboe Europe .. | 576.20 | |
16,825 |
| Cboe Europe .. | 575.60 | |
15,524 |
| Turquoise | 576.00 | |
5,282 |
| Nasdaq Other.. | 633.9200 | |
36 |
| Lang & Schwa.. | 522.800 | |
|
| Mexico | 13,449.09 |  |
290 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
11/10/2020 / 07:00 - GlobeNewswire - Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
09/04/2020 / 07:00 - GlobeNewswire
Real-time